Giulia Marvaso

Giulia Marvaso Highlights Evolving Evidence on SBRT and MDT Strategies at ESTRO25

Giulia Marvaso, Assistant Professor in the Department of Oncology and Hemato-Oncology at the University of Milan and Radiation Oncologist at IEO Milan, shared a post on X:

Live from ESTRO25:
From STOMP , EXTEND to RADIOSA and X-MET—the evidence is growing:
SBRT alone is good.
SBRT + ADT is better.
Personalized MDT strategies are here to stay.
Stronger together”Giulia Marvaso Highlights Evolving Evidence on SBRT and MDT Strategies at ESTRO25

More posts featuring ESTRO25.